Drawing for DEVATIS, INC.

USPTO serial 79304284

DEVATIS, INC.

Reviewed by CopyMark Law Group

Reg. 6430725Status 700Renewal
Filing date
Status date
Registration date
Jul 27, 2021
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DEVATIS, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicholas D. Wells

Nicholas D. Wells Legends Law Group, PLLC330 Main StKaysville, UT 84037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in treating by inhibiting the growth of tumors, as antiparasitics, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, endocrinology disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, hormonal diseases, ophthalmological disease, cancer and diseases of the blood, and for use in treating immune function, psychiatric disorders, fatigue, and sexual disfunction; veterinary preparations for use in treating by inhibiting the growth of tumors, as antiparasitics, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, endocrinology disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, hormonal diseases, ophthalmological disease, cancer and diseases of the blood, and for use in treating immune function, psychiatric disorders, fatigue, and sexual disfunction; sanitary preparations for medical purposes; dietetic foods, namely, food supplements and dietary supplements adapted for medical use; dietetic sugar for medical use; food for babies; dietary supplements for humans and animals; medical plasters; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 23, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 29, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 22, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 22, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 27, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 17, 2021GPNXNOTIFICATION PROCESSED BY IB—
May 11, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 11, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 21, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 21, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 5, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Apr 5, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 5, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 5, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 22, 2021RFNTREFUSAL PROCESSED BY IB—
Mar 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 3, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 2, 2021RFRRREFUSAL PROCESSED BY MPU—
Feb 26, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 19, 2021DOCKASSIGNED TO EXAMINER—
Feb 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 18, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance